Bibliographie (2530)
Coronavirus vaccine strategy needs rethink after resistant variants emerge, say scientists
mardi, 09 février 2021 03:54 Écrit par Zouhair SouissiCoronavirus vaccine strategy needs rethink after resistant variants emerge, say scientists – The Guardian Related: South Africa halts AstraZeneca vaccine rollout over new variant – BBC AND ‘What other variants might be out there?’ An expert on viral evolution on what’s happening with coronavirus mutations – STAT AND Covid-19: Oxford vaccine offers less protection against […]
The post Coronavirus vaccine strategy needs rethink after resistant variants emerge, say scientists appeared first on Links Medicus.
Small RCT: Peginterferon lambda increases viral clearance in outpatients with COVID-19
mardi, 09 février 2021 03:54 Écrit par Zouhair SouissiPeginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial – The Lancet Respiratory Medicine
The post Small RCT: Peginterferon lambda increases viral clearance in outpatients with COVID-19 appeared first on Links Medicus.
Variant-proof vaccines — invest now for the next pandemic
mardi, 09 février 2021 03:54 Écrit par Zouhair SouissiVariant-proof vaccines — invest now for the next pandemic – Nature
The post Variant-proof vaccines — invest now for the next pandemic appeared first on Links Medicus.
Thrombosis and COVID-19: Controversies and (Tentative) Conclusions
mardi, 09 février 2021 03:54 Écrit par Zouhair SouissiThrombosis and COVID-19: Controversies and (Tentative) Conclusions – Clinical Infectious Diseases Commentary on Twitter Excellent review of thrombosis and anticoagulation in #COVID19 by @connors_md and @RMKGandhi Paradoxically, anticoagulation may be most beneficial in moderately ill patients with #COVID19, as the bleeding risk may be excessive in the critically ill https://t.co/75TiNs0iej pic.twitter.com/v0avzhFl3f — John Ross […]
The post Thrombosis and COVID-19: Controversies and (Tentative) Conclusions appeared first on Links Medicus.
RCT: Posaconazole noninferior to voriconazole for primary treatment of invasive aspergillosis
dimanche, 07 février 2021 22:52 Écrit par Zouhair SouissiPosaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial – The Lancet (link to abstract – $ for full-text)
The post RCT: Posaconazole noninferior to voriconazole for primary treatment of invasive aspergillosis appeared first on Links Medicus.
Cohort study: ECMO in patients with severe respiratory failure from COVID-19
dimanche, 07 février 2021 22:52 Écrit par Zouhair SouissiExtracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19 – Intensive Care Medicine Related: ECMO for COVID-19 patients in Europe and Israel – Intensive Care Medicine Commentaries on Twitter #ECMO in #COVID19, multicenter US based study on 5122 critical adults➡️#ECLS in 3.7%, 66.8% of whom survived to hospital discharge or 60 days➡️considerably […]
The post Cohort study: ECMO in patients with severe respiratory failure from COVID-19 appeared first on Links Medicus.
Review: “Silent” Presentation of Hypoxemia and Cardiorespiratory Compensation in COVID-19
dimanche, 07 février 2021 22:52 Écrit par Zouhair Souissi“Silent” Presentation of Hypoxemia and Cardiorespiratory Compensation in COVID-19 – Anesthesia
The post Review: “Silent” Presentation of Hypoxemia and Cardiorespiratory Compensation in COVID-19 appeared first on Links Medicus.
![[Press release – not published yet] Covid-19: Oxford vaccine offers less protection against South Africa variant](/media/k2/items/cache/b184fcc64e2c630bc6793d8e1c9e3f5e_S.jpg)
[Press release – not published yet] Covid-19: Oxford vaccine offers less protection against South Africa variant
dimanche, 07 février 2021 22:52 Écrit par Zouhair SouissiOxford Covid-19 vaccine trial results – University of the Witwatersrand Commentaries: Covid: Oxford jab offers less S Africa variant protection – BBC AND Expert reaction to news reports that the Oxford/AZ vaccine gives limited protection against mild disease caused by the South African variant of SARS-CoV-2 – Science Media Centre AND Oxford/AstraZeneca COVID shot less […]
The post [Press release – not published yet] Covid-19: Oxford vaccine offers less protection against South Africa variant appeared first on Links Medicus.
The good and the (potentially) bad: What scientists know about variants and Covid-19 vaccines
dimanche, 07 février 2021 22:52 Écrit par Zouhair SouissiThe good and the (potentially) bad: What scientists know about variants and Covid-19 vaccines – STAT See also: What Will it Take to Make Covid-19 Vaccines Variant-Proof? – Wired AND What’s Going On With All These Coronavirus Variants? An Illustrated Guide – NPR AND Video: Coronavirus Variants – What They Mean – JAMA
The post The good and the (potentially) bad: What scientists know about variants and Covid-19 vaccines appeared first on Links Medicus.
What’s the risk of dying from a fast-spreading COVID-19 variant?
dimanche, 07 février 2021 22:52 Écrit par Zouhair SouissiWhat’s the risk of dying from a fast-spreading COVID-19 variant? – Nature Original study: Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern 202012/01 – medRxiv
The post What’s the risk of dying from a fast-spreading COVID-19 variant? appeared first on Links Medicus.
![[Press release – not published yet] Sinovac Announces Phase III Results of Its COVID-19 Vaccine](/media/k2/items/cache/19b2674528b4d5fa396dcc8c20062871_XS.jpg)
